Date: November 22, 2023
Source: The Business Standard
Beximco Pharma has been included in the esteemed list of the top 200 publicly listed companies in the Asia-Pacific region published by Forbes Magazine.
Beximco, a leading drug maker in the country, has achieved this prestigious recognition for the third consecutive time.
Rabbur Reza, COO of the company, received the award in a grand ceremony held on Tuesday (21 November 21) in Manila, Philippines.
The US based Forbes Magazine recently published its "Asia's 200 Best Under a Billion" list which spotlights 200 top-performing publicly listed companies in the Asia-Pacific region with annual sales under $1 billion.
Among a vast array of over 20,000 small and midsized companies across the region, these 200 Best Under a Billion companies have track records of exceptional corporate performance.